Advertisement

Showing posts matching the search for severeShow All
Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderate-to-severe atopic dermatitis
Empathy in Action: CARS24 Introduces Industry First Compassion Policy
VENUS REMEDIES SECURES EU GMP RENEWAL FROM INFARMED, STRENGTHENS EUROPEAN MARKET PRESENCE
Titan Company Ltd. and Himmotthan Empower Women & Communities in Uttarakhand, Offset 126 Million Litres of Water over Two Years
Monkeypox
Arpan Launches Groundbreaking #ProtectedByPOCSO Campaign to Combat Child Sexual Abuse in India
JICA extends ODA loan of INR 4,649 crores for Delhi Mass Rapid Transport System Project (Phase 4 Additional Corridors) (I)
Job in Society for Child and Women Empowerment
3.85 lakh Bihar teachers will be transferred and posted in December and January
USAID and Takeda Launch Dengue Prevention Campaign
Grundfosbrings together industry experts forthe ‘10thAnnual Sustainable Water Management Conclave’
“Universal Health Coverage in India: Navigating Challenges and Harnessing Opportunities”
Load More That is All